 |
|
Medicare Part DA Successful Start With Room for Improvement
Dana P. Goldman, PhD;
Geoffrey F. Joyce, PhD
JAMA. 2008;299(16):1954-1955.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Medicare Part D represents a bold experiment to publicly fund, but privately sell and administer, prescription drug insurance. Part D is only a relatively small part of the overall Medicare program; Medicare spent $432 billion overall in 2007, of which Part D accounted for only 11.6% ($50 billion).1 However, the Medicare program is so large that Part D alone should account for 1% of the entire economy in less than 2 decades.1 Furthermore, there is little room for more spending, given the trustees' recent forecast of $12 trillion in unfunded liabilities over the next 75 years—a debt just slightly smaller than the entire US economy.1 So much appears to be riding on Part D's success or failure, including possible models for the provision of health insurance to the currently uninsured. Two articles2-3 in this issue of JAMA raise important concerns about the . . . [Full Text of this Article]
Author Affiliations: RAND Corporation, Santa Monica, California (Drs Goldman and Joyce), and National Bureau of Economic Research, Cambridge, Massachusetts (Dr Goldman).
RELATED ARTICLES
Cost-Related Medication Nonadherence and Spending on Basic Needs Following Implementation of Medicare Part D
Jeanne M. Madden, Amy J. Graves, Fang Zhang, Alyce S. Adams, Becky A. Briesacher, Dennis Ross-Degnan, Jerry H. Gurwitz, Marsha Pierre-Jacques, Dana Gelb Safran, Gerald S. Adler, and Stephen B. Soumerai
JAMA. 2008;299(16):1922-1928.
ABSTRACT
| FULL TEXT
Medicare Beneficiaries' Knowledge of Part D Prescription Drug Program Benefits and Responses to Drug Costs
John Hsu, Vicki Fung, Mary Price, Jie Huang, Richard Brand, Rita Hui, Bruce Fireman, and Joseph P. Newhouse
JAMA. 2008;299(16):1929-1936.
ABSTRACT
| FULL TEXT
|
